Yijun Jia

2.1k total citations
56 papers, 1.6k citations indexed

About

Yijun Jia is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Yijun Jia has authored 56 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 23 papers in Molecular Biology and 21 papers in Immunology. Recurrent topics in Yijun Jia's work include Lung Cancer Treatments and Mutations (19 papers), Cancer Immunotherapy and Biomarkers (15 papers) and Aquaculture disease management and microbiota (15 papers). Yijun Jia is often cited by papers focused on Lung Cancer Treatments and Mutations (19 papers), Cancer Immunotherapy and Biomarkers (15 papers) and Aquaculture disease management and microbiota (15 papers). Yijun Jia collaborates with scholars based in China, United States and Ethiopia. Yijun Jia's co-authors include Sha Zhao, Xuefei Li, Tao Jiang, Chao Zhao, Shengxiang Ren, Chunxia Su, Jinpeng Shi, Bin Zhu, Xiaozhen Liu and Gao‐Xue Wang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Yijun Jia

56 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yijun Jia China 22 793 525 512 474 193 56 1.6k
Beverly S. Chilton United States 20 306 0.4× 155 0.3× 872 1.7× 333 0.7× 140 0.7× 60 1.9k
Satoru Fukuyama Japan 26 628 0.8× 402 0.8× 475 0.9× 1.1k 2.3× 125 0.6× 65 2.2k
Roland Günther United States 24 248 0.3× 253 0.5× 582 1.1× 300 0.6× 49 0.3× 56 1.6k
Kristen Page United States 26 164 0.2× 287 0.5× 555 1.1× 524 1.1× 137 0.7× 39 1.7k
Lan Chen China 21 146 0.2× 301 0.6× 606 1.2× 161 0.3× 68 0.4× 52 1.3k
Francisco J. Salgado Spain 19 377 0.5× 191 0.4× 257 0.5× 195 0.4× 88 0.5× 42 1.1k
T Hayakawa Japan 21 317 0.4× 404 0.8× 441 0.9× 247 0.5× 47 0.2× 107 1.6k
Soeren Lukassen Germany 12 248 0.3× 120 0.2× 489 1.0× 352 0.7× 113 0.6× 19 1.7k
Tomás P. Carroll Ireland 22 485 0.6× 725 1.4× 547 1.1× 395 0.8× 808 4.2× 59 2.0k
Renate Hellmiss United States 11 205 0.3× 483 0.9× 1.4k 2.7× 182 0.4× 184 1.0× 11 2.8k

Countries citing papers authored by Yijun Jia

Since Specialization
Citations

This map shows the geographic impact of Yijun Jia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yijun Jia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yijun Jia more than expected).

Fields of papers citing papers by Yijun Jia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yijun Jia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yijun Jia. The network helps show where Yijun Jia may publish in the future.

Co-authorship network of co-authors of Yijun Jia

This figure shows the co-authorship network connecting the top 25 collaborators of Yijun Jia. A scholar is included among the top collaborators of Yijun Jia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yijun Jia. Yijun Jia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Zhao, Liang Zhao, Xuefeng Wei, Yijun Jia, & Bin Zhu. (2024). Skin as outermost immune organ of vertebrates that elicits robust early immune responses after immunization with glycoprotein of spring viraemia of carp virus. PLoS Pathogens. 20(12). e1012744–e1012744. 1 indexed citations
2.
Li, Zongjuan, Du He, Yijun Jia, et al.. (2024). SLC40A1+ macrophages contribute to the immunosuppressive tumor microenvironment in EGFR-mutated lung cancer. Science Bulletin. 70(1). 47–50. 2 indexed citations
3.
4.
Han, Ruoshuang, Haoyue Guo, Jinpeng Shi, et al.. (2024). Osimertinib in combination with anti-angiogenesis therapy presents a promising option for osimertinib-resistant non-small cell lung cancer. BMC Medicine. 22(1). 174–174. 11 indexed citations
5.
Jia, Yijun, et al.. (2023). Evaluation of epitope vaccine based on phage display technology for largemouth bass virus. Aquaculture. 580. 740288–740288. 4 indexed citations
6.
Zhang, Chen, Zhao Zhao, Yijun Jia, et al.. (2023). Rationally Designed Self-Assembling Nanovaccines Elicit Robust Mucosal and Systemic Immunity against Rhabdovirus. ACS Applied Materials & Interfaces. 16(1). 228–244. 9 indexed citations
7.
Jia, Yijun, et al.. (2022). Antigenic epitope screening and functional modification of mannose enhance the efficacy of largemouth bass virus subunit vaccines. Journal of Fish Diseases. 45(11). 1635–1643. 19 indexed citations
8.
Han, Ruoshuang, Yijun Jia, Xuefei Li, et al.. (2021). Concurrent use of metformin enhances the efficacy of EGFR-TKIs in patients with advanced EGFR-mutant non-small cell lung cancer—an option for overcoming EGFR-TKI resistance. Translational Lung Cancer Research. 10(3). 1277–1291. 16 indexed citations
9.
Jia, Yijun, Xuefei Li, Chao Zhao, et al.. (2020). Soluble PD-L1 as a Predictor of the Response to EGFR-TKIs in Non-small Cell Lung Cancer Patients With EGFR Mutations. Frontiers in Oncology. 10. 1455–1455. 16 indexed citations
10.
Zhang, Binjie, Yijun Jia, Shihua Wu, et al.. (2019). Clinical Effect of Intravenous Vitamin C on Viral Myocarditis in Children: A Systematic Review and Meta-Analysis. Evidence-based Complementary and Alternative Medicine. 2019. 1–9. 8 indexed citations
11.
Zhao, Sha, Guanghui Gao, Wei Li, et al.. (2019). Antibiotics are associated with attenuated efficacy of anti-PD-1/PD-L1 therapies in Chinese patients with advanced non-small cell lung cancer. Lung Cancer. 130. 10–17. 121 indexed citations
12.
Jia, Yijun, Sha Zhao, Tao Jiang, et al.. (2019). Impact of EGFR-TKIs combined with PD-L1 antibody on the lung tissue of EGFR-driven tumor-bearing mice. Lung Cancer. 137. 85–93. 23 indexed citations
13.
Zhang, Chen, Yuying Zheng, Zhao Zhao, et al.. (2019). Evaluation of immune response and protection against spring viremia of carp virus induced by a single-walled carbon nanotubes-based immersion DNA vaccine. Virology. 537. 216–225. 15 indexed citations
14.
15.
Zhao, Sha, Xuefei Li, Chao Zhao, et al.. (2018). Loss of T790M mutation is associated with early progression to osimertinib in Chinese patients with advanced NSCLC who are harboring EGFR T790M. Lung Cancer. 128. 33–39. 34 indexed citations
16.
Jia, Yijun, Weige Wang, Rui Bi, et al.. (2018). Integrative analysis of PD‐L1 DNA status, mRNA status and protein status, and their clinicopathological correlation, in diffuse large B‐cell lymphoma. Histopathology. 74(4). 618–628. 15 indexed citations
17.
18.
Zhang, Limin, Tao Jiang, Chao Zhao, et al.. (2016). Efficacy of crizotinib and pemetrexed-based chemotherapy in Chinese NSCLC patients with ROS1 rearrangement. Oncotarget. 7(46). 75145–75154. 44 indexed citations
19.
Zhao, Sha, Tao Jiang, Limin Zhang, et al.. (2016). Clinicopathological and prognostic significance of regulatory T cells in patients with non-small cell lung cancer: A systematic review with meta-analysis. Oncotarget. 7(24). 36065–36073. 39 indexed citations
20.
Jia, Yijun, Chuanying Wang, Mingjie Zhu, et al.. (2016). Increased chemosensitivity and radiosensitivity of human breast cancer cell lines treated with novel functionalized single-walled carbon nanotubes. Oncology Letters. 13(1). 206–214. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Beverly S. Chilton Breakdown of academic impact, for papers by Satoru Fukuyama Breakdown of academic impact, for papers by Roland Günther Breakdown of academic impact, for papers by Kristen Page Breakdown of academic impact, for papers by Lan Chen Breakdown of academic impact, for papers by Francisco J. Salgado Breakdown of academic impact, for papers by T Hayakawa Breakdown of academic impact, for papers by Soeren Lukassen Breakdown of academic impact, for papers by Tomás P. Carroll Breakdown of academic impact, for papers by Renate Hellmiss
Rankless by CCL
2026